OTLK Outlook Therapeutics, Inc.
0.5900USD+3.15%Mkt Cap: 143.63M $P/E: —1d ago
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an o…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap143.63M USD
Enterprise Value146.44M USD
Revenue (TTM)-1.16M USD
Gross Profit57.21K USD
Net Income (TTM)-62.42M USD
Revenue/Share-0.01 USD
Last Price0.5900 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.77
PEG—
EV/EBITDA-2.64
EV/Revenue-125.86
P/S-119.69
P/B-10.21
EPS (TTM)-0.70
EPS (Forward)-0.12
52W Range
0.161018% of range2.538
52W High2.538 USD
52W Low0.1610 USD
Profitability
Gross Margin4.05%
Oper. Margin-124255.27%
EBITDA Margin0.00%
Profit Margin-4416.22%
ROE193.94%
ROA-335.90%
Growth
Revenue Growth-99.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-51.83M USD
CapEx (TTM)—
FCF Margin3210.85%
FCF Yield-26.01%
Net Debt7.19M USD
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity-0.94
Current Ratio0.81
Quick Ratio0.45
Book Value/Sh-0.06 USD
Cash/Share0.05 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateMar 18, 2019
Splits
Last Split1:20
Split DateMar 14, 2024
Analyst Consensus
Rating—
Target (Mean)5.025 USD
Upside (mean)+751.7%
Target Range1.600 USD – 10.50 USD
1.600+751.7% to mean10.50
# Analysts4
Ownership
Shares Out.243.45M
Float197.82M
Insiders12.64%
Institutions16.67%
Short Interest
Short Ratio2.6d
Short % Float14.02%
Short % Out.13.24%
Shares Short32.22M
Short (prev mo.)19.90M
Technical
SMA 500.7500 (-21.3%)
SMA 2000.7337 (-19.6%)
Beta0.67
S&P 52W Chg16.45%
Avg Vol (30d)11.74M
Avg Vol (10d)4.86M
Technical Indicators
RSI (14)37.8
MACD-0.0644
MACD Signal-0.0745
MACD Hist.+0.0101
BB Upper0.7055 USD
BB Middle0.6317 USD
BB Lower0.5580 USD
BB Width23.36%
ATR (14)0.0589 USD
Vol Ratio (20d)0.90x